Health Professionals Section

NZSSD Expert Opinions on published studies

From time to time the NZSSD Executive invites a member of NZSSD to provide an Expert Opinion on a relevant topical issue. These are intended to stimulate thought and debate within the Society on different aspects of diabetes research and management. Expert opinions are commentaries reflecting the views of the author, and are not formal statements of the Society itself. NZSSD Position Statements can be found elsewhere on this website.


NZSSD Expert Opinion on the use of long-acting insulin analogues (83 KB)


NZSSD Expert Opinion comment on the ACCORD & ADVANCE trials (38KB):

  • 'Effects of Intensive Glucose Lowering in Type 2 Diabetes'.
    N Engl J Med 358:2545-59, June 12, 2008
    Action to Control CardiOvascular Risk in Diabetes (ACCORD) Study Group.
    Read abstract on PubMed link out
  • 'Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.'
    N Engl J Med 358:2560-72, June 12, 2008
    Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) Collaborative Group.
    Read abstract on PubMed link out

NZSSD Expert Opinion comment on the MiG trial (24KB):

  • 'Metformin versus insulin for the treatment of gestational diabetes.'
    N Engl J Med 358(19):2003-15, May 8, 2008
    Rowan JA, Hague WM, Gao W, Battin MR, Moore MP; MiG Trial Investigators.
    Read abstract on PubMed link out

NZSSD Expert Opinion comment on the HAPO study (24KB):

  • 'Hyperglycemia and adverse pregnancy outcomes.'
    N Engl J Med 358(19):1991-2002, May 8, 2008
    HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, Hadden DR, McCance DR, Hod M, McIntyre HD, Oats JJ, Persson B, Rogers MS, Sacks DA.
    Read abstract on PubMed link out